Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.670
+0.020 (0.75%)
At close: Jul 3, 2025, 1:00 PM
2.720
+0.050 (1.87%)
After-hours: Jul 3, 2025, 3:07 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $679.94 million as of July 3, 2025. Its market cap has decreased by -29.10% in one year.
Market Cap
679.94M
Enterprise Value
775.88M
1-Year Change
-29.10%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $679.94M, a decrease of -72.01%. That is a compound annual growth rate of -24.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 384.41M | -50.27% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | 2.75B | 13.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |